Zions Bancorporation’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,484
Closed -$846K 924
2023
Q4
$846K Buy
22,484
+1,113
+5% +$40.9K 0.06% 224
2023
Q3
$963K Buy
21,371
+1,696
+9% +$103K 0.08% 191
2023
Q2
$1.45M Buy
19,675
+273
+1% +$18.4K 0.12% 133
2023
Q1
$1.14M Buy
19,402
+8,240
+74% +$454K 0.1% 167
2022
Q4
$563K Sell
11,162
-166
-1% -$9.97K 0.04% 236
2022
Q3
$986K Buy
11,328
+6,182
+120% +$649K 0.1% 144
2022
Q2
$585K Buy
5,146
+1,066
+26% +$122K 0.06% 219
2022
Q1
$528K Buy
4,080
+1,173
+40% +$169K 0.05% 236
2021
Q4
$525K Buy
2,907
+498
+21% +$86.4K 0.05% 220
2021
Q3
$358K Buy
+2,409
New +$369K 0.04% 246

Other funds holding OMCL

Zions Bancorporation's OMCL Position: Q1 2024 in Review

Zions Bancorporation sold out of Omnicell (OMCL) in Q1 2024, closing a stake of 22,484 shares — an estimated $846K sold.

Zions Bancorporation first reported a position in OMCL in Q3 2021 and held it in 10 quarters. The position peaked at $1.45M in Q2 2023. 267 funds tracked by Wall St. Rank hold OMCL as of Q1 2024.

  • Zions Bancorporation reported no remaining Omnicell position as of Q1 2024 after selling out during the quarter.
  • Zions Bancorporation sold 22,484 Omnicell shares in Q1 2024, an estimated $846K.
  • Zions Bancorporation first reported a position in Omnicell in Q3 2021 and held it in 10 quarters.
  • Zions Bancorporation's Omnicell position peaked at $1.45M in Q2 2023.
  • 267 funds tracked by Wall St. Rank held Omnicell as of Q1 2024.

Based on Zions Bancorporation's 13F filing for Q1 2024, filed 14 May 2024.